References:
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020/01/24. 2020 February 15;395(10223):497–506. Available from: https://pubmed.ncbi.nlm.nih.gov/31986264
2. Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Reports [Internet]. 2021 January 1;9(1):461–4. Available from: https://doi.org/10.1002/ccr3.3557
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet [Internet]. 2020 January 30;395(10224):565–74. Available from: https://doi.org/10.1016/s0140-6736(20)30251-8
4. Akbarpour M, Sharifi L, Safdarian AR, Farhangnia P, Borjkhani M, Rezaei N. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV. In: Rezaei N, editor. Coronavirus Disease - COVID-19 [Internet]. Cham: Springer International Publishing; 2021. p. 149–67. Available from: https://doi.org/10.1007/978-3-030-63761-3_9
5. Wu Z, Yang D. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res [Internet]. 2020;25(1):54. Available from: https://doi.org/10.1186/s40001-020-00454-x
6. Gurala D, Al Moussawi H, Philipose J, Abergel JR. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease. Cureus [Internet]. 2020 Aug 26;12(8):e10045–e10045. Available from: https://dx.doi.org/10.7759%2Fcureus.10045
7. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal liver function tests. J Hepatol [Internet]. 2020;73(3):566–74. Available from: https://doi.org/10.1016/j.jhep.2020.04.006
8. Marjot T, Webb GJ, Barritt AS, Moon AM, Stamataki Z, Wong VW, et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol [Internet]. 2021; Available from: https://doi.org/10.1038/s41575-021-00426-4
9. Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol [Internet]. 2020 May 1;5(5):428–30. Available from: https://doi.org/10.1016/S2468-1253(20)30057-1
10. Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, et al. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol [Internet]. 2020 June 1;18(7):1561–6. Available from: https://doi.org/10.1016/j.cgh.2020.04.002
11. Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, et al. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology [Internet]. 2020 September 1;72(3):807–17. Available from: https://doi.org/10.1002/hep.31404
12. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology [Internet]. 2020 Jul;159(1):320-334.e27. Available from: https://doi.org/10.1053/j.gastro.2020.05.001
13. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA [Internet]. 2020 May 26;323(20):2052–9. Available from: https://doi.org/10.1001/jama.2020.6775
14. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med [Internet]. 2020 April 17;382(24):2372–4. Available from: https://doi.org/10.1056/NEJMc2010419
15. Ponziani FR, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Pompili M, et al. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther [Internet]. 2020 Sep;52(6):1060–8. Available from: https://doi.org/10.1111/apt.15996
16. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int [Internet]. 2020 Sep;40(9):2095–103. Available from: https://doi.org/10.1111/liv.14455
17. Fu Y, Zhu R, Bai T, Han P, He Q, Jing M, et al. Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study. Hepatology [Internet]. 2021 April 1;73(4):1509–20. Available from: https://doi.org/10.1002/hep.31446
18. Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut [Internet]. 2021 April 1;70(4):807 LP – 809. Available from: http://dx.doi.org/10.1136/gutjnl-2020-322072
19. Lei F, Liu Y-M, Zhou F, Qin J-J, Zhang P, Zhu L, et al. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology [Internet]. 2020 Aug;72(2):389–98. Available from: https://doi.org/10.1002/hep.31301
20. Bangash MN, Patel JM, Parekh D, Murphy N, Brown RM, Elsharkawy AM, et al. SARS-CoV-2: Is the liver merely a bystander to severe disease? [Internet]. Vol. 73, Journal of hepatology. 2020. p. 995–6. Available from: https://doi.org/10.1016/j.jhep.2020.05.035
Table 1. Laboratory Data.